| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(05)80066-2 |
| P8608 | Fatcat ID | release_7tm57ijd5ffejcajpxrwfmgquu |
| P698 | PubMed publication ID | 8006407 |
| P2093 | author name string | F Marumo | |
| N Enomoto | |||
| M Kurosaki | |||
| C Sato | |||
| P2860 | cites work | Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 |
| Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
| Clinical backgrounds of the patients having different types of hepatitis C virus genomes | Q42980988 | ||
| Marked sequence diversity in the putative envelope proteins of hepatitis C viruses | Q42981195 | ||
| Long-term follow-up of patients with chronic hepatitis C treated with α-interferon | Q42981340 | ||
| Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus | Q42981586 | ||
| Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha | Q42982978 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Severity of liver disease with different hepatitis C viral clones | Q42985421 | ||
| Typing of hepatitis C virus genomes by restriction fragment length polymorphism | Q42985883 | ||
| Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection | Q43038615 | ||
| Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non‐A, non‐B chronic liver disease | Q43038687 | ||
| The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronic hepatitis | Q43048083 | ||
| There are two major types of hepatitis C virus in Japan | Q43993360 | ||
| Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant | Q45018234 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 | ||
| Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer | Q27486595 | ||
| Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes | Q29620921 | ||
| Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins | Q29620952 | ||
| Hypervariable regions in the putative glycoprotein of hepatitis C virus | Q33334316 | ||
| Rapid evolution of RNA viruses | Q34174014 | ||
| Construction of mutant and chimeric genes using the polymerase chain reaction | Q35862419 | ||
| Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys | Q36683893 | ||
| Recombinant alpha-interferon treatment of non-A, and non-B (type C) hepatitis: review of studies and recommendations for treatment | Q37833358 | ||
| Enhanced Mutability Associated with a Temperature-Sensitive Mutant of Vesicular Stomatitis Virus | Q39814501 | ||
| P433 | issue | 2 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 252-261 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene | |
| P478 | volume | 20 |
| Q40466498 | Alpha interferon treatment of chronic hepatitis C |
| Q45066635 | Biology of hepatitis C viruses: clinical implications |
| Q41056018 | Clinical relevance of hepatitis C virus quasispecies |
| Q43038220 | Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues |
| Q39469211 | Detection of evolving viruses |
| Q43037097 | Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment |
| Q42981084 | Duration of HCV infection as a predictor of nonresponse to interferon |
| Q27485656 | Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing |
| Q43032254 | Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients |
| Q43037341 | Efficacy of combination therapy with interferon and azidothymidine in chronic type C hepatitis: a pilot study |
| Q43036688 | Evolution of viral quasispecies in four dominant HlA-A2 restricted T cell epitopes is not a major reason for viral persistence in interferon-treated patients with chronic hepatitis C. |
| Q41700693 | Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection. |
| Q43037741 | Fraction‐specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia |
| Q43035657 | Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients |
| Q42981053 | Predictors of response to interferon therapy |
| Q42989240 | Review article: interferon and hepatitis C—factors predicting therapeutic outcome |
| Q42980251 | Selection of hepatitis C virus quasispecies during interferon treatment |
| Q40957762 | The long-term efficacy of interferon alfa in chronic hepatitis C patients: a critical review |
| Q27469342 | Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees |
Search more.